UNSPSC 51183509: Metformin glycinate

This classification denotes an anti-diabetic agent C4H11N5.C2H5NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YEI21W005Y, chemically known as glycine, compd. with n,n-dimethylimidodicarbonimidic diamide (1:1), but more generally known as metformin glycinate, which bears US NIH Compound Identifier 44520175. Most nations, for tariff and trade purposes, schedule metformin glycinate under HS 29252900 and SITC 51482. As of Q4 2014, METFORMIN GLYCINATE remains US FDA's Preferred Term for this commodity.

SMILES: CN(C)C(=N)NC(=N)N.C(C(=O)O)N.

UNSPSC 51183509 Metformin glycinate, a Commodity code, addresses state and local procurement of this specific pharmaceutical formulation, a combination of the antidiabetic agent metformin with the amino acid glycine. State and local governments procure metformin glycinate primarily through health departments, correctional facilities, and public hospital systems to support treatment of type 2 diabetes and related metabolic conditions in covered populations. The work involves sourcing, quality assurance, and supply chain management of the finished pharmaceutical product rather than manufacturing or compounding. Issuing bodies include state health and human services departments, county correctional facilities, municipal hospitals, and public health clinics that maintain formularies and pharmaceutical inventories for indigent care, incarcerated populations, and employees.

The source provided contains no recent state and local contract opportunities tagged to this code. Without posted RFPs, RFQs, IFBs, or ITBs in the opportunities block, geographic activity cannot be characterized and representative solicitations cannot be named. Metformin glycinate as a discrete UNSPSC commodity may see procurement activity in certain states with high incarceration rates or large public hospital systems, but the absence of recent postings signals either limited recent demand under this specific formulation code, consolidation of pharmaceutical procurement into broader family-level codes or master vendor agreements, or use of alternative classification schemes by state and local procurement offices. Firms should verify current demand by checking state health department pharmaceutical RFQs, county correctional-facility supply contracts, and municipal hospital formulary updates directly, as the code shows no recent visible activity in posted opportunities.